Corpus Intelligence IC Memo — PORTER REGIONAL HOSPITAL 2026-04-26 06:38 UTC
IC Memo — PORTER REGIONAL HOSPITAL
Investment Committee Memorandum | IN | 199 beds | Grade C | EBITDA uplift $27.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PORTER REGIONAL HOSPITAL

CCN 150035 | PORTER, IN | 199 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PORTER REGIONAL HOSPITAL is a 199-bed suburban community hospital in PORTER, IN with $370.6M in net patient revenue and a 22.1% operating margin. The hospital serves a payer mix of 33.8% Medicare, 3.9% Medicaid, and 62.3% commercial.

Thesis: Turnaround. Our ML models identify $27.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 22.1% to 29.5% (+736bps).

Net Revenue HCRIS$370.6M
Current EBITDA COMPUTED$82.0M
Operating Margin COMPUTED22.1%
Occupancy HCRIS72.9%
Revenue / Bed COMPUTED$1.9M
Net-to-Gross HCRIS14.4%
Distress Probability ML40.8%

2. Market Context & Competitive Position

171
IN Hospitals
-1.1%
State Median Margin
43
Comparable Hospitals

IN has 171 Medicare-certified hospitals with a median operating margin of -1.1%. The target's margin of 22.1% places it above the state median. Among 43 size-comparable peers (100-398 beds), the median margin is 3.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (100-398), prioritizing same-state peers. 43 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PORTER REGIONAL HOSPITAL (Target)IN199$370.6M22.1%
COMMUNITY HEALTH NETWORK INC.IN387$1.24B16.4%
ASCENSION ST. VINCENT EVANSVILIN346$671.8M11.4%
UNION HOSPITAL INC.IN258$581.9M3.8%
LUTHERAN HOSPITAL OF INDIANAIN335$580.1M3.8%
COMMUNITY HOSPITAL OF INDIANA IN340$565.2M12.0%
ESKENAZI HEALTHIN314$562.3M-50.0%
IU HEALTH BLOOMINGTON HOSPITALIN210$529.4M6.2%
BALL MEMORIAL HOSPITALIN316$524.9M0.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $27.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$7.8M+210bp18mo
Cost to Collect4.5%2.5%$7.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$7.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$4.5M+122bp9mo
Clean Claim Rate88.0%96.0%$237K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$7.8M
Cost to Collect
$7.4M
Denial Rate Reduction
$7.3M
A/R Days Reduction
$4.5M
Clean Claim Rate
$237K
Total EBITDA Uplift$27.3M
Current EBITDA$82.0M
+ RCM Uplift+$27.3M
Pro Forma EBITDA$109.2M
Current Margin22.1%
Pro Forma Margin29.5%
WC Released (1x)$14.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$126.1M$813.4M6.45x45.2%
Base (11x exit)10.0x11.0x$126.1M$935.7M7.42x49.3%
Bull Case9.0x11.0x$113.5M$1.07B9.40x56.5%
Bull (12x exit)9.0x12.0x$113.5M$1.20B10.55x60.2%
Bear Case11.0x10.0x$138.7M$636.0M4.59x35.6%
Bear (11x exit)11.0x11.0x$138.7M$744.7M5.37x40.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 43 hospitals with 100-398 beds
  • Same-state prioritization (n=44)
  • Comp margins: P25=-12.9% / P50=3.8% / P75=12.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.